GlassScriptPhysician profile
Christopher D Lawley
NPI 1558372789
$8,611.81
in general payments reported to CMS, 2019-2025
38 companies · $816 in 2025
The $816 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,326 · 2020: $788 · 2021: $1,558 · 2022: $945 · 2023: $1,044 · 2024: $2,136 · 2025: $816.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,273 · Travel and Lodging: $390 · Education: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,273.45 |
| Travel and Lodging | $389.55 |
| Education | $332.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,379.56 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $860.01 | 2023-2025 | Orgovyx, Gemtesa |
| Janssen Biotech, INC. | $846.30 | 2019-2025 | Erleada |
| Abbvie INC. | $624.81 | 2019-2025 | |
| Neotract INC. | $620.61 | 2019-2020 | |
| Antares Pharma, INC. | $544.20 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Medtronic, INC. | $427.41 | 2021-2025 | Interstim, Altaviva |
| Procept Biorobotics Corporation | $412.21 | 2024 | Aquabeam System |
| Boston Scientific Corporation | $410.78 | 2019-2025 | Lithovue, Ams 700, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $338.30 | 2023-2024 | Provenge |
| Myovant Sciences INC. | $298.21 | 2021-2022 | |
| Clarus Therapeutics INC. | $191.88 | 2021 | |
| Pfizer INC. | $182.99 | 2019-2024 | |
| Endo Pharmaceuticals INC. | $144.78 | 2019-2022 | |
| Teleflex LLC | $129.06 | 2024 | Urolift |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $122.19 | 2019-2024 | |
| Blue Earth Diagnostics | $120.09 | 2021-2022 | |
| Accord Healthcare, INC. | $106.39 | 2023-2025 | |
| Tosoh Bioscience, INC. | $95.00 | 2019 | |
| Axonics, INC. | $92.15 | 2021-2024 | Axonics |
| Urovant Sciences INC | $88.58 | 2021-2022 | |
| Acerus Pharmaceuticals Corporation | $85.52 | 2020-2022 | |
| Dornier Medtech America, INC | $74.25 | 2022 | |
| Endo USA, INC. | $55.61 | 2024-2025 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $54.12 | 2024-2025 | |
| Verity Pharmaceuticals INC. | $41.54 | 2024-2025 | Tlando |
| Progenics Pharmaceuticals, INC. | $40.46 | 2023 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $37.10 | 2019-2021 | |
| Convatec INC. | $33.16 | 2023 | |
| Tolmar, INC. | $33.14 | 2023-2025 | Jatenzo |
| Telix Pharmaceuticals | $26.29 | 2023 | Illuccix |
| Allergan, INC. | $25.52 | 2019-2021 | |
| Biotissue Holdings INC. | $18.07 | 2023 | |
| Amgen INC. | $14.44 | 2019 | |
| Aytu Biopharma, INC. | $12.80 | 2019 | |
| Medtronic USA, INC. | $12.25 | 2020 | |
| Coloplast Corp | $12.03 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Lawley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.